Maravai LifeSciences Holdings, Inc. (MRVI) vs Xencor, Inc. (XNCR)
- Maravai LifeSciences Holdings, Inc. MRVI 6.79 −3.96%
- Xencor, Inc. XNCR 22.95 −4.38%
Maravai LifeSciences Holdings, Inc. and Xencor, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Xencor, Inc. are of similar size ($1.8B and $1.8B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: −5.03% against −28.6%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−37.1% vs −155.6%) and the higher return on invested capital (−15.8% vs −288.7%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 13 and Xencor, Inc. on 5.
Valuation
Profitability
| Metric | MRVI | XNCR | Biotechnology median |
|---|---|---|---|
| Gross margin | 34.89% | 100.00% | 65.16% |
| Operating margin | (56.08%) | (205.84%) | 0.00% |
| Net margin | (37.07%) | (155.59%) | 0.00% |
| Free cash flow margin | (17.17%) | (198.42%) | 0.00% |
| Return on equity | (18.79%) | (29.07%) | (56.36%) |
| Return on assets | (10.31%) | (20.36%) | (48.04%) |
| Return on invested capital | (15.83%) | (288.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack